Immuno-Biological Laboratories Co., Ltd.'s market cap is currently ¥4.46B. The company's EPS TTM is ¥6.54; its P/E ratio is 17.21; Immuno-Biological Laboratories Co., Ltd. is scheduled to report earnings on August 8, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in JPY
Immuno-Biological Laboratories Co., Ltd. Earnings and Revenue History
